Kozak & Associates’s Eli Lilly LLY Stock Holding History

Kozak & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.9K	Hold	50	–	–	0.01%	137
2026 Q1	$46.8K	Sell	50 -10	-17%	-$10.1K	0.01%	154
2025 Q4	$64.1K	Hold	60	–	–	0.01%	131
2025 Q3	$61.6K	Buy	60 +35	+140%	+$26K	0.01%	136
2025 Q2	$19.8K	Hold	25	–	–	﹤0.01%	194
2025 Q1	$19K	Hold	25	–	–	﹤0.01%	176
2024 Q4	$19.6K	Buy	25 +10	+67%	+$8.28K	﹤0.01%	182
2024 Q3	$14.1K	Hold	15	–	–	﹤0.01%	208
2024 Q2	$13.8K	Sell	15 -1	-6%	-$800	﹤0.01%	204
2024 Q1	$12.1K	Buy	16 +1	+7%	+$712	﹤0.01%	219
2023 Q4	$9.73K	Sell	15 -7	-32%	-$4.09K	﹤0.01%	237
2023 Q3	$12.6K	Buy	22 +15	+214%	+$7.73K	﹤0.01%	218
2023 Q2	$3.36K	Hold	7	–	–	﹤0.01%	285
2023 Q1	$2.49K	Hold	7	–	–	﹤0.01%	294
2022 Q4	$3K	Hold	7	–	–	﹤0.01%	290
2022 Q3	$2K	Hold	7	–	–	﹤0.01%	301
2022 Q2	$2K	Hold	7	–	–	﹤0.01%	338
2022 Q1	$2K	Hold	7	–	–	﹤0.01%	351
2021 Q4	$2K	Hold	7	–	–	﹤0.01%	351
2021 Q3	$2K	Buy	+7	New	+$1.73K	﹤0.01%	306

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Kozak & Associates's LLY Position: Q2 2026 in Review

Kozak & Associates held its Eli Lilly (LLY) position steady in Q2 2026 at 50 shares worth $59.9K. The position accounts for 0.01% of the portfolio, ranked #137.

Kozak & Associates first reported a position in LLY in Q3 2021 and has held it in 20 quarters since. The position peaked at $64.1K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Kozak & Associates held 50 shares of Eli Lilly worth $59.9K as of Q2 2026.
Kozak & Associates left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.01% of Kozak & Associates's portfolio in Q2 2026, its #137 holding.
Kozak & Associates first reported a position in Eli Lilly in Q3 2021 and has held it in 20 quarters since.
Kozak & Associates's Eli Lilly position peaked at $64.1K in Q4 2025.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.